Notice Number: NOT-GM-20-023
Key Dates
Release Date: February 20, 2020
Issued by
National Institute of General Medical Sciences (NIGMS)
Purpose
This Notice is to inform potential applicants to PAR-20-103 "Collaborative Program Grant for Multidisciplinary Team Research (RM1 Clinical Trial Optional)" and PAR-20-104 "Biomedical Technology Development and Dissemination Center (RM1- Clinical Trial Not Allowed)" of an upcoming webinar on planning submissions to these Funding Opportunity Announcements (FOAs). Participation in the webinar, although encouraged, is optional and is not required for application submission.
Webinar Information
Thursday, March 5, 3:00-4:00 p.m. Eastern Time
The Collaborative Program Grant for Multidisciplinary Team Research announcement is unique to NIGMS. This program has been reissued with some important changes that will be discussed. The Biomedical Technology Development and Dissemination Center program replaces, in part, activities previously supported by the NIGMS Biomedical Technology Research Resource Center (P41) program. Although both of the new programs use the RM1 activity code, there are major differences that will be explained during the webinar.
For both grant programs, the research must be within the research mission of NIGMS. The Collaborative Program Grant for Multidisciplinary Teams FOA supports highly integrated research teams of 3 to 6 PDs/PIs to address ambitious and challenging research questions that are important for the mission of NIGMS and are beyond the scope of one or 2 investigators. Project goals should not be achievable with a collection of individual efforts or projects. Applications that are mainly focused on the creation, expansion, and/or maintenance of community resources, creation of new technologies, or infrastructure development are not appropriate for this FOA.
The Biomedical Technology Development and Dissemination (BTDD) Centers program will support development of technologies once their feasibility has been established, as well as the dissemination of these technologies to the wider biomedical research community. Major changes from the P41 BTRR program include emphasis on later stage development, community access, and dissemination of new technology; simpler application and administration processes; and elimination of the optional X02 pre-application. Program goals are still addressed through Technology Development Projects, Driving Biomedical Projects, and Community Engagement activities.
During this webinar, the Institute director and other NIGMS staff will discuss these two new FOAs and answer questions from potential applicants.
To attend the webinar, please Join WebEx meeting shortly before 3:00 p.m. Eastern Time.
Meeting number (access code): 628 841 986
Meeting password: nigms
You can also attend by phone by calling 650-479-3208.
Join using Microsoft Lync or Microsoft Skype for Business
Dial [email protected]
Join from a video system or application
Dial [email protected]
You can also dial 173.243.2.68 and enter your meeting number.
Slides will be posted on the Collaborative Program Grant For Multidisciplinary Teams (RM1) page of the NIGMS website.
Questions can be submitted during the webinar using the chat feature or at any time via email to [email protected]v.
Inquiries
Please direct inquiries about the Collaborative Program Grant for Multidisciplinary Teams inquiries to:
Peter C. Preusch, Ph.D.
National Institute of General Medical Sciences (NIGMS)
Email: [email protected]
Please direct inquiries about the Biomedical Technology Development and Dissemination Centers to:
Haluk Resat, Ph.D.
National Institute of General Medical Sciences (NIGMS)
Email: [email protected]
and Human Services (HHS)
